Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices 40781 

for both oral and written public comments 

will be provided to the IPRCC for their 

consideration and will become part of the 

public record. 

The meeting will be open to the public and 

webcast live on the Internet. If you 

experience any technical problems with the 

webcast, please call the NIH IT Service Desk 

at (301) 496–4357, toll free (866) 319–4357, 

for webcast issues. 

Individuals who participate in person or by 

using the web service and who need special 

assistance, such as captioning, should submit 

a request to the Contact Person listed on this 

notice at least seven days prior to the 

meeting. 

As a part of security procedures, attendees 

should be prepared to present a photo ID 

during the security process to get on the NIH 

campus. For a full description, please see: 

http://www.nih.gov/about/ 

visitorsecurity.htm. 

Information about the IPRCC is available 

on the Web site: http://iprcc.nih.gov/. 

Dated: August 23, 2017. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18200 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Initial Review Group; Neuroscience of 

Aging Review Committee. 

Date: October 5–6, 2017. 

Time: 2:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Greg Bissonette, Ph.D., 

Scientific Review Officer, National Institute 

on Aging, National Institutes of Health, 

Gateway Building, Suite 2W200, 7201 

Wisconsin Avenue, Bethesda, MD 20892, 

301–402–1622, bissonettegb@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: August 23, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18198 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center For Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group; Basic Mechanisms of Cancer 

Therapeutics Study Section. 

Date: September 18–19, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Double Tree Suites by Hilton. 1707 

Fourth Street. Santa Monica, CA 90401. 

Contact Person: Lambratu Rahman Sesay, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, 301–451– 

3493, rahman-sesayl@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Biomedical 

Imaging Technology A Study Section. 

Date: September 26–27, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Ruth Grossman, DDS, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5215, 

Bethesda, MD 20892, (301) 435–2409, 

grossmanrs@mail.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Medical Imaging 

Study Section. 

Date: September 26–27, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Xiang-Ning Li, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5112, 

MSC 7854, Bethesda, MD 20892, 301–435– 

1744, lixiang@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Clinical Molecular 

Imaging and Probe Development. 

Date: September 26–27, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Donald Scott Wright, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

8363, wrightds@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Biomedical 

Imaging Technology B Study Section. 

Date: September 26–27, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Mehrdad Mohseni, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5211, 

MSC 7854, Bethesda, MD 20892, 301–435– 

0484, mohsenim@csr.nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group; Lung Cellular, Molecular, and 

Immunobiology Study Section. 

Date: September 26–27, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Resort Hotel, 998 West 

Mission Bay Drive, San Diego, CA 92109. 

Contact Person: George M. Barnas, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2180, 

MSC 7818, Bethesda, MD 20892, 301–435– 

0696, barnasg@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel, PAR 16– 

304: Behavioral and Psychological 

Phenotypes Contributing to Obesity. 

Date: September 26, 2017. 

Time: 4:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
40782 Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Stacey FitzSimmons, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7808, Bethesda, MD 20892, 301–451– 

9956, fitzsimmonss@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–17– 

275: Mammalian Models for Translational 

Research. 

Date: September 27, 2017. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Careen K Tang-Toth, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, (301)435– 

3504, tothct@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 22, 2017. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18119 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Proposed Project: Evaluation of the 

Projects for Assistance in Transition 

From Homelessness (PATH) Program— 

New 

SAMHSA is conducting the federally 

mandated Evaluation of the PATH 

program. The PATH grant program, 

created as part of the Stewart B. 

McKinney Homeless Assistance 

Amendments Act of 1990, is 

administered by SAMHSA’s CMHS’ 

Homeless Programs Branch. The PATH 

program is authorized under Section 

521 et seq. of the Public Health Service 

(PHS) Act, as amended. The SAMHSA 

PATH program funds each Fiscal Year 

the 50 states, the District of Columbia, 

Puerto Rico, and four U.S. Territories 

(the U.S. Virgin Islands, Guam, 

American Samoa, and the 

Commonwealth of the Northern Mariana 

Islands). The PATH grantees make 

grants to local, public and non-profit 

organizations to provide the PATH 

allowable services. 

The SAMHSA Administrator is 

required under Section 528 of the PHS 

Act to evaluate the expenditures of 

PATH grantees at least once every three 

years to ensure they are consistent with 

legislative requirements and to 

recommend changes to the program 

design or operations. 

The primary task of the PATH 

evaluation is to meet the mandates of 

Section 528 of the PHS Act. The second 

task of the PATH evaluation is to 

conduct additional data collection and 

analysis to further investigate the 

sources of variation in key program 

output and outcome measures that are 

important for program management and 

policy development. The PATH 

evaluation builds on the previous 

evaluation which was finalized in 2016 

and was conducted as part of the 

National Evaluation of SAMHSA 

Homeless Programs. The PATH 

evaluation will use web surveys, 

telephone interviews and site visits to 

facilitate the collection of information 

regarding the structures and processes 

in place at the grantee and provider 

level. Data regarding the outputs and 

outcomes of the PATH program will be 

obtained from grantee applications, 

providers’ intended use plans (IUPs) 

and from PATH annual report data, 

which is also required by Section 528 of 

the PHS Act and is approved under 

OMB No. 0930–0205. 

Web Surveys will be conducted with 

all State PATH Contacts (SPCs) and staff 

from intermediary and PATH provider 

organizations. The Web Surveys will 

capture detailed and structured 

information in the following topics: 

Selection, monitoring and oversight of 

PATH providers; populations served; 

the PATH allowable or eligible services 

provided; sources for match funds; 

provision of training and technical 

assistance; implementation of Evidence 

Based Practices (EBPs) and innovative 

practices including SOAR; data 

reporting, use of data and the Homeless 

Management Information System 

(HMIS); and collaboration, coordination 

and involvement with Continuums of 

Care (CoCs) and other organizations. 

The SPCs for all grantees (n = 56), the 

Project Directors from the PATH 

provider organizations (n = 500) and 

staff from the intermediary 

organizations (n = 28) will be contacted 

to complete the web surveys. The Web 

Surveys will be administered once. 

Site Visits will be conducted with a 

purposive sample of PATH grantees and 

providers to collect more nuanced 

information than will be possible with 

the web survey. Semi-structured 

discussions will take place with the 

SPCs, grantee staff, PATH provider staff 

including the Project Director and other 

key management staffs, outreach 

workers, case managers and other 

clinical treatment staff, key stakeholders 

at the grantee and provider level and 

consumers. Five grantees will be 

selected for Site Visits and visited 

within each grantee will be one to two 

PATH providers. The Site Visits will be 

utilized to collect information regarding: 

Provider and state characteristics; 

practices and priorities; context within 

which the grantees and providers 

operate; and services available within 

the areas the providers operate. Also, 

discussed will be the successes, barriers, 

and strategies faced by PATH grantees 

and providers. Focus groups will be 

held with current or former consumers 

of the PATH program to obtain 

consumer perspectives regarding the 

impact of the programs. The Site Visits 

will be conducted once. 

Telephone Interviews will be 

conducted with a sample of SPCs (n = 

28) and intermediary (n = 14) and 

provider staff (n = 60) to explore 

through open-ended questions in greater 

detail, explanations for variations 

among providers in measures that are 

important for program management and 

policy development. The outputs of the 

PATH program include: The number of 

persons receiving PATH-funded 

services, outreached/contacted and 

enrolled; the number of services 

provided; and the number of referrals 

provided. The outcome evaluation will 

be limited, given limitations in available 

data and will include the number of 

persons referred to and attaining 

substance use treatment, primary health 

services, job training, educational 

services, housing services, housing 

placement assistance, income 

assistance, employment assistance and 

medical assistance. The Telephone 

interviews will be conducted once. 

The estimated burden for the 

reporting requirements for the PATH 

evaluation is summarized in the table 

below. 


asabaliauskas on DSKBBXCHB2PROD with NOTICES